Aims The transcription factor early growth response-1 (Egr-1) is increased in models of cardiac pathology; however, it is unclear how Egr-1 impacts the heart. We sought to identify how Egr-1 regulates expression of proteins involved in cardiomyocyte calcium homeostasis. Methods Protein expression was measured by immunoblotting in control cardiac differentiated H9c2 cells or in H9c2 cells overexpressing wild-type Egr-1 (Egr-1) or an Egr-1 (I293F) mutant. Microspectrofluorimetry of fura-2-loaded cells was used to study calcium dynamics. Chromatin immunoprecipitation with anti-Egr-1 antibody was used to identify Egr-1-associated DNA. Results Calsequestrin (CSQ) expression was reduced in Egr-1-and profoundly reduced in I293F-expressing cells. Calreticulin, triadin, sarcoendoplasmic reticulum ATPase 2a, phospholamban, and phosphoserine 16-phospholamban expression was unaffected. Calcium release from CSQ-dependent ryanodine-sensitive stores was reduced in Egr-1 and absent in I293F-expressing cells. In contrast, calcium release from calreticulin-dependent inositol 1,4,5-trisphosphate stores was unaffected. In vivo and in vitro chromatin immunoprecipitation demonstrated Egr-1 binding to the CSQ2 promoter. The Egr-1-binding region contains overlapping Egr-1, SP1, and nuclear factor of activated T-cells (NFAT) sites and a CpG island. Reciprocal immunoprecipitation coupled to immunoblots indicated Egr-1:NFAT3 binding was present in all cells lines. Treatment with cyclosporin A, inhibition of DNA methylation using 5-azadeoxycytidine, or inhibition of protein acetylation using sodium butyrate reduced CSQ expression. Conclusion Our data suggest that Egr-1:DNA binding at the promoter, DNA methylation, and protein acetylation are important in CSQ repression. Moreover, we demonstrate that a reduction in CSQ protein is associated with abnormal calcium dynamics. We conclude that Egr-1 acts as a transcriptional repressor at the CSQ promoter, resulting in downregulation of CSQ, the major calcium storage protein that links excitation-contraction coupling in the cardiac sarcoendoplasmic reticulum.
Introduction
Members of the early growth response gene (Egr) family are the transcription factors Egr-1, Egr-2, Egr-3, Egr-4, and Wilm's tumour protein-1. 1 Egr family members are most homologous in their zinc finger DNA-binding domain and all bind to GC-rich recognition motifs. Egr-1 is a 533 amino acid nuclear protein with activation (a.a. 1-218), repression (R1) (a.a. 281-314), and sequence-specific zinc finger DNAbinding domains (a.a. 332-419) (reviewed in ref.
2 ). The NGFI-A-binding proteins 1 and 2 (NAB1 and NAB2) are Egr family-specific co-repressors. 3, 4 In non-cardiac cells, Egr-1-dependent signalling is influenced by Egr-1 binding to cell proteins such as the nuclear factor of activated T-cells (NFAT) 1 5, 6 or p300/CBP. 7 Egr-1 expression is increased in animal models of heart disease. 8, 9 Egr-1-binding sites are present in such genes as atrial natriuretic factor and b-myosin heavy chain, often altered in rodent hypertrophy. Egr-12/2 mice are viable 10 but show a reduced ability to withstand stress 11, 12 suggesting that Egr-1 is involved in cardiac remodelling. Calcium homeostasis is vitally important to cardiac function. 13 Calcium entering cardiomyocytes triggers calcium release from the sarcoendoplasmic reticulum (SER) to initiate contraction. Relaxation is established by the combined action of sodium calcium exchanger-1 (NCX1) to † These authors contributed equally to this work.
remove calcium to the cell exterior and the sarcoendoplasmic reticulum ATPase (SERCA2a) to re-sequester calcium to the SER. Calcium is stored in the SER principally by lowaffinity high-capacity calsequestrin (CSQ) binding.
14 When calcium is high in the SER, CSQ forms linear polymers that have a high calcium-binding capacity. When calcium is reduced, CSQ binds to ryanodine receptor 2 (RyR2) to reduce calcium release. Thus, CSQ participates in calcium storage and release.
In a previous report, we showed Egr-1 negatively regulated NCX1 expression 15 in vivo and in vitro in cardiac differentiated H9c2 cells. The Egr-1-mediated decrease in NCX1 expression prompted us to examine other proteins involved in maintaining calcium homeostasis in cardiomyocytes. In this report, we show that Egr-1 represses CSQ expression.
Methods

Materials
Immobilon P membrane was from Millipore (Bedford, MA, USA). CSQ, calreticulin (CRT), SERCA2a, and phospholamban (PLB) polyclonal antibodies were from Affinity BioReagents (Golden, CO, USA). Phosphoserine 16-phospholamban (pS 16 -PLB) was from Upstate Biotechnology Inc. (Charlottesville, VA, USA). Sodiumpotassium ATPase (NKA) a subunit antibody developed by Douglas Fambrough (Johns Hopkins, Baltimore, MD, USA) was from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biological Sciences, The University of Iowa (Iowa, IA, USA). NFAT3 antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). NAB mouse monoclonal antibody was a gift from Dr Judith Johnson (GE). Glycerol acetylphosphate dehydrogenase (GAPDH) and tubulin (Tub) were from Sigma-Aldrich (St Louis, MI, USA). Secondary antibodies and enhanced chemiluminescent detection kits were from Pierce (Rockford, IL, USA). Chelex 100 molecular biology grade resin was from Bio-Rad (Hercules, CA, USA). Protein A Sepharose CL-4B was from GE Healthcare (Chicago, IL, USA). Fura-2 was from InVitrogen, (Carlsbad, CA, USA). All other chemicals were from Sigma-Aldrich.
Cell culture and manipulations
The rat ventricular cell line, H9c2, was cultured in DMEM/10% foetal bovine serum. H9c2 cells overexpressing cytomegalovirus immediate-early (CMV) promoter-driven wild-type Egr-1 (Egr-1) or CMV-driven I293F Egr-1, harbouring a mutation in the R1 region (I293F), were described previously. 16 To reduce Egr-1 expression, Egr-1 cDNA was placed in the reverse direction under CMV control in pcDNA3.1 (CMV-AS) and stable cell lines isolated. Cells were cardiac differentiated by culture in reduced serum (1%) and daily additions of 10 28 M retinoic acid for 4 days. Cell density was measured using the Sulphorhodamine B dye-binding method that measures cell protein. 16 Cells were plated in triplicate in a 24-well plate and were differentiated. Cells were washed, fixed, incubated with Sulphorhodamine B, washed, and bound dye eluted with alkali. Dye binding was measured by absorbance at 600 nM.
5-Azadeoxycytidine (0.1, 0.5, or 1.0 mM) was added to freshly plated cells 3 days prior to differentiation, the cells differentiated for 4 days and then harvested. Sodium butyrate (4 mM) or cyclosporin A (10 mM) was added during the last 2 days of differentiation.
Protein isolation and immunoblot analysis
Cells were homogenized in SDS lysis buffer (62.5 mM Tris, pH 6.8, 2% w/v SDS, 10% glycerol, 50 mM DTT, and 0.01% w/v bromophenol blue). Heart ventricle was homogenized in RIPA buffer [50 mM Tris (pH 7.4), 1% NP-40, 0.5% Na deoxycholate, 0.1% SDS, 150 mM NaCl, complete protease inhibitors (Roche, Indianapolis IN, USA), 1 mM Na vanadate, and 1 mM PMSF], then clarified by centrifugation. Protein concentrations were determined using the Bio-Rad Protein Determination Assay (Bio-Rad).
Protein expression was measured by semiquantitative immunoblots as described. 16 Antibodies (CSQ antibody was diluted 1:2500, SERCA2a and CRT 1:500, NFAT3 and PLB 1:200, pS 16 -PLB 1:1000, NAB2 1:10, triadin 1:100, NKA 1:5000, and GAPDH 1:10000) in TBST þ 3% milk were incubated overnight at 48C. Horseradish-peroxidase-coupled secondary antibodies were diluted 1:20 000 and incubated for 1 h at room temperature. Chemiluminescent detection of specific binding followed the instructions from the manufacturer. Immunoblots were repeated at least three times from at least three independent experiments.
Reciprocal co-immunoprecipitation and immunoblots
Cardiac differentiated H9c2 cells were fixed with 1% formaldehyde and lysed in RIPA buffer as described above. Antibody, Egr-1 or NFAT3, or normal serum control was added and protein complexes collected by Protein A Sepharose beads. The immunoprecipitation (IP) lysate was subjected to standard immunoblot analysis as described above.
In vivo and in vitro chromatin immunoprecipitation
Mouse ventricles were minced and incubated in DMEM/1% formaldehyde and then in 1 M glycine. Nuclei were isolated and chromatin immunoprecipitation (ChIP) was performed using anti-Egr-1 or normal rabbit sera and Chelex-100 to collect DNA. 17 Cardiac differentiated H9c2 cells were treated as above. PCR was performed using DNA isolated prior to antibody incubation (input DNA) or after immunoprecipitation (IP DNA). Primers specific for the mouse or rat CSQ2 promoter (Tables 1 and 2) were used in DNA amplifications, as appropriate. Negative controls contained all reagents except DNA. Amplification used Taq DNA polymerase and 36 cycles. ] i was monitored using microspectrofluorimetry. 18 Cells were loaded with 1.5 mM fura-2-AM then the media replaced with physiological buffer (130 mM NaCl, 5 mM KCl, 10 mM glucose, 1 mM MgCl 2 , 1 mM CaCl 2 , and 20 mM HEPES, pH 7.4). Changes in fluorescent emission at 510 nm, following alternate excitation at 340 and 380 nm [managed by high-speed wavelength-switching device, Lambda DG-4; Quorum Technologies (East Winstead, UK)] recorded with a CCD camera [Hamamatsu (Hamamatsu, Japan)], were collected and analysed using image analysis software [Velocity Improvision (Coventry, UK)]. Caffeine (0.5 mM) or ATP (0.1 mM) was administered by bath application.
Fluorescence measurement of cytosolic free
Densitometry and statistical analyses
X-ray films were scanned using an HP Scanjet 5100C and HP Precision Scan Software (Hewlett-Packard, Palo Alto, CA, USA). The areas under the peaks were quantified using ScionImage Release Beta 3 Software (National Institutes of Health, Bethesda, MD, USA). Test protein expression was standardized to GAPDH or Tub expression measured on the same blot. Values are expressed as the mean + SD. Comparisons used the Student's t-test. A P-value of ,0.05 was considered significant.
Results
Characterization of Egr-1 overexpressing H9c2 cell lines
Egr-1 overexpressing H9c2 cells were described previously. 15 A schematic of Egr-1 domains is presented in Figure 1A .
Wild-type Egr-1 (Egr-1) or I293F point mutation (I293F) stable cell lines overexpressed 3-fold control H9c2 level of Egr-1 ( Figure 1B) . H9c2, Egr-1, and I293F cultures had similar densities as estimated by the Sulphorhodamine B dye binding indicating that there was no difference in cell growth with time post-differentiation ( Figure 1C ).
Regulation of sarcoendoplasmic reticulum protein expression by Egr-1
To determine whether Egr-1 affected the expression of SER proteins, we measured expression of proteins involved in SER calcium regulation, SERCA2a, PLB, and pS 16 -PLB, proteins involved in calcium release from the SER, triadin, and CSQ, a calcium-binding protein of the ER, CRT, and proteins uninvolved in calcium homeostasis, NKA and GAPDH as a consequence of Egr-1 or I293F overexpression ( Figure 2) .
Baseline CSQ expression was equivalent in undifferentiated H9c2 and Egr-1 but reduced in I293F cells (Figure 2A) . The increase in CSQ expression with differentiation was less (P , 0.05) in Egr-1 compared with H9c2 cells. CSQ expression increased with differentiation in the I293F but did not approach baseline H9c2 or Egr-1 levels. Although the amount of increase varied CRT (Figure 2A) , SERCA2a, triadin, PLB, and pS 16 -PLB, ( Figure 2B ) expression was significantly (P , 0.05) induced post-differentiation in all cell lines. NKA expression was unaffected by differentiation or Egr-1 expression.
To determine whether reduced Egr-1 would impact CSQ expression, we transfected CMV-driven antisense (AS) Egr-1 DNA onto H9c2 cells and isolated stable clones. Egr-1 expression was reduced in the AS clones by 70% ( Figure 2C ). CSQ expression was significantly increased in cardiac differentiated AS cells ( Figure 2C) . Although basal caffeine levels did not change, there was a significant Egr-1 and calsequestrinincrease in the amplitude of caffeine-induced calcium response from in H9c2 cells (1.1 + 0.1 ratio units) compared with AS cells (2.8 + 0.6 ratio units, n ¼ 5, P , 0.05). CSQ expression was increased in ventricular heart homogenates from Egr-1 deficient mice and reduced in hearts of Egr-1 transgenic mice compared with normal heart ( Figure 2D ).
To determine whether the Egr-1 co-repressor NAB2 was altered in the cells and could account for the reduction in CSQ expression, we measured NAB2 expression. NAB2 was increased by differentiation similarly and to equivalent levels in all cell lines ( Figure 2E ). Figure 3A) . Caffeine induces calcium release from SER stores. Almost half (44 + 19%) of the H9c2 cells responded to caffeine application with elevation of [Ca 2þ ] i , which peaked and then declined slowly, even in the continued presence of caffeine ( Figure 3B) Figure 4) ; however, the average amplitude of calcium responses was significantly reduced in I293F cells (0.37 + 0.04 ratio units, n ¼ 5) compared with H9c2 cells (0.73 + 0.11 ratio units, n ¼ 17, P , 0.01).
Effect of Egr-1 activity on calcium dynamics
Egr-1 protein binds to the CSQ2 promoter
To determine whether Egr-1 bound to CSQ promoter DNA, we performed ChIP. We performed in vivo ChIP using anti-Egr-1 antibodies, mouse ventricle nuclei, and mouse-specific CSQ2 primers (Table 1, Figure 5A ). Amplification of input DNA with all primer pairs was equivalent (data not shown). DNA was amplified only with primers specific for mouse CSQ2 region 2 (R2) ( Figure 5B), indicating that Egr-1 binds to mouse CSQ2 promoter DNA between 21801 and 21019. Amplification was detected in H9c2 cells only with primers designed to amplify the 21497 to 21269 of the rat CSQ2 promoter (Table 2, Figure 5B ). Comparisons and alignment of the mouse and rat DNA sequence suggest that Egr-1 binds to CSQ2 promoter DNA between 21650 and 21000 of the mouse genome.
To identify putative transcription factor-binding sites, we analysed the mouse homologous DNA region. Egr-1, SP1, and NFAT sites were identified in R2 using rVISTA and Transfac programmes ( Figure 5C ). MethylPrimer identified a CpG island in R2. SP1 expression was unaffected by differentiation or Egr-1 overexpression ( Figure 5D ). To determine whether altered DNA methylation impacted CSQ expression, we treated H9c2 cells with the methylation inhibitor 5-aza-deoxycytidine. CSQ expression was reduced by culture in media with increasing amounts of 5--aza-deoxycytidine ( Figure 5E ). Egr-1 can be acetylated. To determine whether altered acetylation altered CSQ expression, we treated cells with the histone deacetylase inhibitor, sodium butyrate. CSQ expression was reduced with culture in media containing the sodium butyrate ( Figure 5F ).
Egr-1/NFAT3 interaction and calsequestrin regulation
NFAT consensus-binding sequences were identified in the R2 region. To determine whether NFAT expression was affecting CSQ expression, we measured NFAT3 expression in cell homogenates. NFAT3 was increased with differentiation in H9c2 and Egr-1 but not I293F cell lines ( Figure 6A ). Egr-1 and NFAT1 can form heterodimers. To determine whether Egr-1 and NFAT3 could also form heterodimers, we performed reciprocal immunoprecipitation and immunoblot assays using anti-Egr-1 and anti-NFAT3 antibodies in H9c2, Egr-1, and I293F cells. We found Egr-1:NFAT3 heterodimer formation in all cells ( Figure 6B) . To become active, NFAT translocation to the nucleus requires dephosphorylation by calcineurin. Culture in media containing the calcineurin inhibitor, cyclosporin A, had no effect in H9c2 cells but reduced CSQ expression in Egr-1 and I293F cells ( Figure 6C ).
Discussion
Our results demonstrate reduced CSQ expression and reduced [Ca 2þ ] i in cardiac differentiated H9c2 cells when Egr-1 is increased and a profound repression when I293F is expressed. Reduced [Ca 2þ ] i with caffeine stimulation indicates defective calcium release from SER stores suggesting that reduced CSQ expression has physiological consequences to calcium homeostasis. CSQ deficient mice 20 had no alteration in CRT expression. Similarly, we did not detect compensatory changes in CRT, SERCA2a, or PLB and, importantly, no reduction in triadin calcium homeostasis proteins in our cells and no change in basal calcium levels. The greater reduction in CSQ in I293F cells correlated with the greater defect in calcium signalling in response to caffeine. However, I293F cells responded to ATP, an agonist that targets IP3-sensitive ER stores through activation of P2Y receptors. 21 The decreased amplitude of the calcium response to ATP in I293F cells compared with H9c2 cells suggests that IP3 induces calcium release from both CRT-and CSQ-dependent stores. 22 All cells had similar levels of SERCA2a, PLB, and pS 16 -PLB proteins. This suggests but does not prove that SERCA2a-facilitated calcium transport into the SER from the cytosol is unaffected by Egr-1 activities and is similar among the cells. CSQ2 and RyR2 co-localized, as measured by immunofluorescence staining, in H9c2, Egr-1, and I293F cells (see Supplementary material online, Figure S1 ). H9c2 cells had distinct aggregates of CSQ and RyR2 particularly near the plasma membranes, whereas the pattern of both proteins in Egr-1 and I293F cells was less punctuate and more diffuse. The formation of aggregates suggests that while CSQ had oligomerized in H9c2 cells, there was less oligomerization in Egr-1 and I293 F cells. Assembly of the CSQ2:RyR2 complex may be compromised. Although not quantitative, RyR2 immunofluorescence staining was reduced in Egr-1 and I293F cells. It is unclear if Egr-1 also negatively affects RyR2 expression or if reductions in CSQ2 expression secondarily impacts CSQ2:RyR2 complex formation and RyR2 expression. However, limitations in SER [Ca 2þ ] i are consistent with CSQ reduction as a determining factor. Thus, in vivo data in the CSQ deficient mice and our in vitro data consistently show that when CSQ is reduced SER calcium dynamics is also reduced.
CSQ repression was more profound in I293F than Egr-1 overexpressing cells. The I293F mutation ablates binding to the Egr family co-repressor NAB. In other studies, the I293F point mutation increased transactivation up to 17-fold. 23 NAB proteins do not bind DNA and do not influence Egr-1 DNA-binding affinity but are thought to repress transcription through interactions with basal transcription apparatus or chromatin. Consistent with a capability for NAB-mediated repression, we previously detected NABdependent NCX1 repression. 16 The presence of NAB protein, repression by NAB of other cardiac proteins, and the protective action of NAB overexpression in vivo 24 argues that cardiac cells respond to Egr-1:NAB heterodimers. Our data support the idea that Egr-1 represses expression by NAB-and non-NAB-dependent mechanisms in heart.
Our data suggest that Egr-1-mediated repression occurs at the CSQ promoter. Upstream regions of the mouse CSQ2 gene contain muscle-specific and non-muscle-specific motifs. 25 Our ChIP data suggests that Egr-1 binds within or around 21654 to 21000 of the mouse CSQ2 promoter. rVISTA and Transfac analyses identified a consensus Egr-1-binding site within this region as well as overlapping SP1 and NFAT sites. Egr-1 represses b1-adrenergic receptor expression by binding at overlapping SP1 sites, 26 therefore, it is likely that Egr-1 could bind not only to its own but also to the overlapping SP1 sites in CSQ R2 DNA. The overlapping SP1 sites also contain putative NFAT-binding sites. NFAT can form dimers with neighbouring transcription factors on promoter DNA 27 and recent data indicate that Egr-1 and NFAT1 cooperate in gene activation. 5, 6 Our data now show that Egr-1 and I293F form heterodimers with NFAT3 suggesting that NAB binding does not influence Egr-1:NFAT3 heterodimer formation. NFAT3 levels do not change with Egr-1 expression but the decrease in CSQ expression with cyclosporin A treatment in both Egr-1 and I293F cells argues that a reduction in nuclear NFAT increases CSQ repression. The implication is that increased Egr-1 activates NFAT, which then counteracts this effect on CSQ expression. This suggests that whereas Egr-1 represses CSQ expression NFAT increases CSQ expression. In the absence of NFAT activation, CSQ is repressed.
Reduced DNA methylation and reduced protein deacetylation impacts CSQ repression. DNA methylation of CpG pairs in CpG islands within promoter regions can alter binding by transcription factors, such as Egr-1 and SP1, which bind to GC-rich consensus sequences. 28, 29 MethylPrimer identified a CpG island within mouse CSQ2 region 2 that is differentially methylated (Calve et al., unpublished observation). CSQ repression after culture with the DNA methylation inhibitor, 5-azadeoxycytidine, suggests that reduced methylation of CpG pairs within the CSQ2 promoter increases repression. The data are consistent with the idea that reduced DNA methylation promoted Egr-1 binding to CSQ2 to increase CSQ repression. Egr-1 binds to and is acetylated by p300/CBP at consensus KDKK sites. Acetylation both increased and decreased the expression depending on the target promoter. 7 Culture of H9c2, Egr-1, and I293F cells with the deacetylase inhibitor sodium butyrate reduced CSQ expression in all cell lines. Thus, reduced deacetylation reduced CSQ expression. The data suggest that acetylated Egr-1 represses CSQ expression.
Our data shows that Egr-1 represses CSQ expression yet the repression did not involve NAB proteins. Egr-2, primarily expressed in neurons, repressed transcription when complexed with the neuron-specific protein Ddx20/DP103. 30 Egr-1 increased heparinase expression in prostate cells but reduced heparinase expression in melanoma cells. 31 These data substantiate the idea that Egr-1 regulation can activate or repress expression and that cell-type specific proteins influence the direction of Egr-1 regulation. It also suggests that mechanisms of regulation are likely to be cell-type and tissue specific.
Maintaining CSQ expression is critically important for normal cardiac function. Mutations in CSQ2 resulting in either truncated or missense CSQ2 protein are associated with cardiomyopathy, tachycardia, and sudden cardiac death. 32 Deletion or modest reductions (25%) in CSQ expression in mice resulted in viable mice that developed arrhythmias. 20, 33 Thus, lack of CSQ2 activity has a negative impact on cardiac function in vivo and as we now show in vitro.
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